Answers are grounded in this paper and cite their sources.
Persistent müllerian duct syndrome (PMDS) is a rare form of male pseudohermaphroditism occurring in 46,XY males and is caused by a defect in either the gene for the müllerian-inhibiting substance (MIS) or its type 2 receptor. Patients with this syndrome present with retained müllerian ducts and unilateral or bilateral undescended testes; they may also display crossed testicular ectopia caused by herniated uterine structures (MacLaughlin and Donahoe, 2004; Belville et al, 2004). Sexual ambiguity, PMDS particularly, is also present in other species, such as mixed-breed dogs and goats (Meyers-Wallen, 1993; Kuiper et al, 2004; Josso et al, 2005). In this article, we report the history of a 46-year-old man with a scrotal mass, diagnosed as syringoid eccrine carcinoma, presenting with PMDS, which was incidentally discovered by magnetic resonance imaging (MRI) performed for presurgery stadiation of the scrotal tumor. To our knowledge, this is the first case of an exceptional association between an unusual form of male pseudohermaphroditism and a rare cutaneous tumor in an unusual site, probably due to a previous reconstructive surgery for hypospadia. Patient. A 46-year-old man presented to our unit for endocrinologic evaluation of a sexual ambiguity documented by MRI that showed an upper vagina and a formed uterus. The MRI was performed for a presurgical tumoral stadiation of a cancer diagnosed 7 months before (Figure 1). A subsequent cystoscopy showed a feminine urethra and a small prostate as well. . Presurgical sagittal (A) and transversal (B) magnetic resonance imaging demonstrates a formed uterus (10 × 3 cm) with nonhematic fluid inside, an upper vagina, a bladder, and cavernous bodies. Patient history revealed several urologic operations for hypospadia and monolateral orchiectomy for an undescended testis. One year before admission to our unit, the patient observed a scrotal mass and underwent surgery for scrotectomy, during which the remaining left testis was inserted into the inguinal canal. Because the initial histologic picture was unclear, he was referred to the urology unit of our hospital with acute urinary retention. A urethroscopic exam revealed a protruding lesion infiltrating the urethral lumen. Presurgical MRI showed an upper vagina and a formed uterus; however, no tumor metastases were recorded (Figure 1). The lesion was indeed invasive, infiltrating the perineal region, and required a demolitive and reconstructive surgery of the perineal region. However, due to his well-defined male sexual behavior, the patient refused penectomy. Histology showed an eccrine tumor (Figure 2), consisting mainly of numerous tubular structures, small cords, and nests extending from the reticular dermis to the subcutaneous tissue (Figure 2A and B), which often form syringoma-like ducts. Periodic acid- Schiff—positive diastase-resistant material was observed in the lumina of the tubular structures (Figure 2C). Immunohistochemical analysis revealed diffuse positivity for carcinoembryonic antigen (Figure 2D), cytokeratin (CK) 7 (Figure 2E), and CK 8, 18, and 19 (Figure 2F), suggesting a sweat gland secretory differentiation. . A syringoid eccrine carcinoma of the scrotal-perineal region was diagnosed according to (A and B) classic histology, (C) histochemistry, and (D through F) immunohistochemical features. A, hematoxylin-eosin, 20×; B, hematoxylin-eosin, 40×; C, periodic acid- Schiff—diastase, 200×; D, carcinoembryonic antigen immunostain, 40×; E, cytokeratin 7 immunostain, 40×; and F, cytokeratin 8, 18, 19 immunostain, 40×. In our endocrine unit, the full endocrinologic evaluation showed a hypergonadotropic hypogonadism. The levels of the remaining hormone were within the normal range (Table 1). Karyotype was male (46,XY), and the patient had a normal testicular response to human chorionic gonadotropin (hCG; basal testosterone of 8.7 nmol/L rose to 24.9 nmol/L after intramuscular administration of 5000 IU of hCG) (Figure 3). . Testosterone (black line) and estradiol (dotted line) values after intramuscular injection of human chorionic gonadotropin (5000 IU). Because of the histologic features and the limited consistency of the remaining perineal tissue, neither chemotherapy nor radiotherapy was advised by the oncologist. After 3 months the patient underwent another operation because the tumor had spread in the perineal region and lower abdomen and anal stenoses developed, which required colostomy. The patient is currently still alive and has experienced several subocclusive abdominal episodes, which significantly worsened his quality of life. Antimüllerian hormone (AMH), also called MIS, is a 140-kDa glycoprotein produced by Sertoli cells at the initiation of testicular differentiation and is responsible for the regression of the müllerian ducts, the first sign of phenotypic sex differentiation in the male fetus. Mutations of the AMH or AMH type II receptor (AMHR2) gene lead to a rare form of autosomal recessive male pseudohermaphroditism, named PMDS and characterized by the persistence of müllerian derivates, uterus, fallopian tubes, and upper part of the vagina in normally virilized 46,XY males. Affected individuals are otherwise normally virilized, undergo normal male puberty, and may be fertile if the testes, tightly attached to the fallopian tubes, can be returned into the scrotum. PMDS is also described in other species, such as mixed-breed dogs, cats, and goats (Meyers-Wallen et al, 1993; Kuiper et al, 2004; Josso et al, 2005). In humans, diagnosis is based on clinical features (eg, persistence of müllerian ducts) that may be documented occasionally by radiologic exams and in prepubertal boys, by measurement of AMH levels. Indeed, prenatal AMH expression levels are high in boys and negligible in girls. In boys, the serum concentration of the hormone is low at birth, rapidly rises to peak values during late infancy, and then slowly decreases to the adult range at puberty. Therefore, hormones, such as inhibin and AMH, specifically reflect Sertoli cell function, offering a noninvasive measurement of seminiferous tubular integrity. Moreover, AMH inhibits the differentiation and proliferation of Leydig cell precursors and down-regulates androgen steroidogenesis in mature Leydig cell tumor lines (Misra et al, 2002). PMDS can also be associated with complete androgen insensitivity (Swanson and Coronel, 1993). More recently Klattig et al (2007) focused attention on the fact that Wilms tumor protein WT1 is an activator of the AMHR2 gene, underlining a molecular mechanism behind the association of PMDS and this type of pediatric cancer. Clinical features of PMDS frequently observed are cryptorchidism, inguinal hernia, and very rarely, transverse testicular ectopia, the condition of both testes descending through the same inguinal canal into the same scrotal sac (Berkmen, 1997; Kella et al, 2005; Tiryaki et al 2005; Liang et al, 2006; Boleken et al, 2007). Anorchia may be present as well, suggesting a further defect of embryogenesis, in addition to the failure of müllerian duct regression. Different neoplasms have been ascribed to PMDS. Carcinoma cells may develop from testes or müllerian ducts. Monolateral or bilateral seminoma is the most frequent tumor reported to be associated with PMDS (Snow et al, 1985; van Laarhoven et al, 1991; Williams et al, 1994; Dueñas et al, 2001; Bucci et al, 2002; Yuksel et al, 2006). Conversely, only 1 case of nonseminomatous testicular tumor has been described (Eastham et al, 1992). Similarly, 1 case of mixed germ cell tumor of the testis (teratoma and embryonal carcinoma), diagnosed 18 years after bilateral orchidopexy (Manassero et al, 2004), and a case of choriocarcinoma with teratoma arising from intra-abdominal testis have been reported (Narlawar et al, 2001; Giri et al, 2004). A case of tumor in a supernumerary abdominal testis (polyorchidism) in a man has been described as well (Kulkarni et al, 1992). A clear adenocarcinoma of the müllerian duct, discovered incidentally at autopsy, has been diagnosed, and it represents the first case of malignant transformation of the persistent müllerian duct structures in PMDS (Shinmura et al, 2002). Here we report the first case of PMDS associated with a very rare skin tumor, a syringoid eccrine carcinoma, occurring in an unusual site. However, this patient had a history of several operations for hypospadia during the prepubertal age, when skin borders from other body regions were added for reconstructive surgery. Malignant appendage tumors with eccrine differentiation are a rare group of neoplasms with biologic capacity for local tissue infiltration and metastases. The etiology of these tumors is very complex (Goldestein et al, 1982; Murphy and Elder, 1991). It is possible to separate them into 2 groups: 1) malignant variants that include benign eccrine neoplasms and 2) primary eccrine carcinomas without benign counterparts. Syringoid eccrine carcinoma (Moy et al, 1991; Evans et al, 1995), otherwise called malignant chondroid eccrine syringoma, syringomatous carcinoma, and in some cases, microcystic adnexal carcinoma (McKee et al, 1990) or sclerosing sweat duct carcinoma (Cooper et al, 1985), can be included in the first group. It is usually found on the upper lip, nasolabial area, periorbital region, and less frequently on the axilla, scalp, and trunk (Mehregan et al, 1983; Ohnishi et al, 2002). It occurs on the dermis but often extends into the subcutis or deeper. Metastases rarely occur, but local recurrences of these tumors may be massive; therefore, their complete primary surgical excision is very important. In this case, the tumor was found in the perineal scrotal skin, an unusual site. It was aggressive with an infiltrative growth pattern and multiple local recurrences with abdominal invasion. Indeed, 6 months after the major demolitive and reconstructive surgery, a colostomy was performed because constipation developed due to the neoplastic invasion of the rectal and anal tracts. To our knowledge, this is the first case in the literature of an exceptional association between PMDS and a syringoid eccrine carcinoma of the perineal-scrotal skin. However, in our opinion, this is not likely due to a molecular link. The most probable reason was the previous reconstructive urologic surgery (implants from different cutaneous area) performed for hypospadia several years earlier.
No takes yet. Share an insight, caveat, or question.
Goglia et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: